[Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
D001859:Bone Neoplasms / Q000188:drug therapy; D002369:Castration; D003534:Cyproterone / Q000627:therapeutic use*; D004967:Estrogens / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D013120:Spinal Cord Neoplasms / Q000188:drug therapy
D004967:Estrogens; D003534:Cyproterone
Intérêt du cyprotérone dans le traitement des cancers prostatiques avec métastases